Company: MDCXW
Filing Date: 2025-04-25
Form Type: DRS
Source: 0001062993-25-007956
Chunk: 218

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-25
Form: DRS
Chunk 218
---
 |     |  1,461,250 |     |     5,470,000 |     |               - |     | -           |   |     |   5,470,000 |   |
| Issuance of common shares and warrants in connection with initial public offering, net of issuance costs of $2,218,014 |     |    970,000 |     |     1,075,983 |     |         708,708 |     | -           |   |     |   1,784,691 |   |
| Stock-based compensation                                                                                               |     |          - |     |             - |     |         713,119 |     | -           |   |     |     713,119 |   |
| Net loss and comprehensive loss for the year                                                                           |     |          - |     |             - |     |               - |     | (11,155,516 | ) |     | (11,155,516 | ) |
| Balance as of December 31, 2024                                                                                        |     | 11,816,721 |     |    30,518,195 |     |       1,520,412 |     | (28,903,903 | ) |     |   3,134,704 |   |

The accompanying notes are an integral part of these consolidated financial statements. F-7

Medicus Pharma Ltd.
Consolidated Statements of Cash Flows
(expressed in United States dollars)

| Cash flows from operating activities:                                       |   | Years Ended December 31, 
                     2024 |   |   |       2023 |   |
|:----------------------------------------------------------------------------|:--|-------------------------:|:--|:--|-----------:|:--|
| Net loss for the year                                                       | $ |              (11,155,516 | ) | $ | (5,314,765 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |   |                          |   |   |            |   |
| Stock-based compensation expense                                            |   |                  713,119 |   |   |     98,585 |   |
| Non-cash interest expense                                                   |   |                   74,005 |   |   |    584,820 |   |
| Change in operating lease right-of-use assets                               |   |                   88,234 |   |   |          - |   |
| Changes